The 30-month period during which an ANDA first-filer must obtain tentative approval or face forfeiture of its rights to 180-day marketing exclusivity begins to run on the day after the application is filed, FDA said in a Jan. 26 citizen petition response.
In a June 2012 petition, Sandoz Inc. challenged Ranbaxy Laboratories Ltd.’s eligibility for generic marketing exclusivity on